PATENT CLAIM ANALYSIS

Application Number: 16130242
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "661000"]

Abstract:
The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl.

Claim (Index 145):
The method of  claim 142 , wherein the daily dose is about 40 mg.

Metadata:
- Claim Count in Document: 99.0
- Percentile: 97.0
- Lexical Diversity: 1.03846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13085338', '13359381', '13055418', '12352473', '13645187']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6700859314128212
- 35 USC 102 Novelty (BERT): 0.5416973446511916
- Combined Prediction Score: 0.6572470727366583
- Mean Citation Score: 228.86555400000003
- Max Citation Score: 360.00668
- Similarity Product: 241.92107386519908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test